Short-term Cost Comparison of Systemic Heparin Therapy vs. Catheter Directed Thrombolysis for the Treatment of Massive and Submassive Pulmonary Embolism with Long-Term Chronic Pulmonary Hypertension Cost Model.

Kristopher Johnson,Angela VandenHull,Tyler Remund,Kathryn Pohlson, Valerie Bares, James Wacker,Patrick Kelly

South Dakota medicine : the journal of the South Dakota State Medical Association（2021）

引用 0|浏览2

暂无评分

摘要

For patients with massive or submassive PE, this study demonstrated a significant long-term cost savings and improved outcomes for patients treated with catheter directed thrombolysis when compared to systemic heparin administration.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要